SCHEMBL745074

SCHEMBL745074

O=C1CCC[CH]N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7435324 0.92
SCHEMBL7431565 0.90 CRBN (0.39)
SCHEMBL7432250 0.90 CRBN (0.39)
SCHEMBL7430101 0.90
SCHEMBL75552 0.82
SCHEMBL522543 0.80 CRBN (0.40)
SCHEMBL1646396 0.74
SCHEMBL828805 0.68
SCHEMBL896392 0.67
SCHEMBL9579603 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1997495-B1 2-phenoxy- and 2-phenylsulfanyl-benzenesulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders AXIKIN PHARMACEUTICALS INC (US) 2013-01-02 EP claimed
EP-2229374-A1 AMIDO-THIOPHENE COMPOUNDS AND THEIR USE AS 11-BETA-HSD1 INHIBITORS THE UNIVERSITY OF EDINBURGH (GB) 2010-09-22 EP claimed
US-20090181966-A1 PGD2 receptor antagonists for the treatment of inflammatory diseases MILLENNIUM PHARMACEUTICALS, INC. (US) 2009-07-16 US claimed
WO-2009074789-A1 AMIDO-THIOPHENE COMPOUNDS AND THEIR USE AS 11-BETA-HSD1 INHIBITORS THE UNIVERSITY OF EDINBURGH (GB) 2009-06-18 WO claimed
EP-1608374-B9 2-PHENOXY- AND 2-PHENYLSULFOMAMIDE DERIVATIVES WITH CCR3 ANTAGONISTIC ACTIVITY FOR THE TREATMENT OF ASTHMA AND OTHER INFLAMMATORY OR IMMUNOLOGICAL DISORDERS ACTIMIS PHARMACEUTICALS INC (US) 2009-04-08 EP claimed
EP-1997495-A1 2-phenoxy- and 2-phenylsulfanyl-benzenesulfonamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders Actimis Pharmaceuticals, Inc., (US) 2008-12-03 EP claimed
EP-1991215-A1 USE OF INHIBITORS OF SCAVENGER RECEPTOR CLASS PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES Cenix Bioscience GmbH (DE) 2008-11-19 EP claimed
EP-1608374-B1 2-PHENOXY- AND 2-PHENYLSULFOMAMIDE DERIVATIVES WITH CCR3 ANTAGONISTIC ACTIVITY FOR THE TREATMENT OF ASTHMA AND OTHER INFLAMMATORY OR IMMUNOLOGICAL DISORDERS ACTIMIS PHARMACEUTICALS INC (US) 2008-11-05 EP claimed
EP-1680420-A4 COMPOUNDS, COMPOSITIONS, AND METHODS CYTOKINETICS INC (US) 2008-09-24 EP claimed
WO-2007101710-A1 USE OF INHIBITORS OF SCAVENGER RECEPTOR CLASS PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES CENIX BIOSCIENCE GMBH (DE) 2007-09-13 WO claimed
EP-1368311-A1 DELTA1 -PYRROLINES USED IN PEST CONTROL Bayer CropScience AG (DE) 2003-12-10 EP claimed
WO-2003067986-A1 Δ1 PYRROLINES AND THE USE THEREOF IN PEST CONTROL BAYER CROPSCIENCE AG (DE) 2003-08-21 WO claimed
WO-2002064561-A1 $G(D)1-PYRROLINES USED IN PEST CONTROL BAYER CROPSCIENCE AG (DE) 2002-08-22 WO claimed
US-6355615-B1 CYCLIC POLYAMIDEESTER COPOLYMERS BAYER AKTIENGESELLSCHAFT (DE) 2002-03-12 US claimed
EP-0986549-A1 DESOXYCYCLODEPSIPEPTIDES AND THEIR USE FOR COMBATTING ENDOPARASITES Bayer Aktiengesellschaft (DE) 2000-03-22 EP claimed
WO-1998055469-A1 DESOXYCYCLODEPSIPEPTIDES AND THEIR USE FOR COMBATTING ENDOPARASITES BAYER AKTIENGESELLSCHAFT (DE) 1998-12-10 WO claimed
EP-0406119-B1 New peptide derivatives, process of their preparation and pharmaceutical compositions containing them ADIR (FR) 1994-01-19 EP claimed
US-5098888-A Cholinergic agents and antispasmodic agents ADIR ET COMPAGNIE (FR) 1992-03-24 US claimed
EP-0217688-B1 PEPTIDE DERIVATIVES WITH A LACTONIC OR CYCLOAMIDIC STRUCTURE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ADIR ET COMPAGNIE (FR) 1990-09-26 EP claimed
US-4725581-A NERVOUS SYSTEM DISORDERS, COGNITION ACTIVATORS ADIR ET COMPAGNIE (FR) 1988-02-16 US claimed